Syringe-exchange programs and HIV prevention: If they're effective, what's the controversy?

American Journal of Nursing

Volumn 106, Issue 5, 2006, Pages 58-63

  Villarreal, Holly ^a   Fogg, Catherine ^b,c,d  

^a CHRISTUS Santa Rosa Hospital   (United States)

^b SAINT ANSELM COLLEGE   (United States)

^c Merrimack Valley Assistance Program   (United States)

^d UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646836453     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200605000-00025     Document Type: Review

References (40)

1. UNAIDS, World Health Organization. Introduction. In: AIDS epidemic update: December 2005. Geneva, Switzerland: UNAIDS; 2005. p. 2-5. http://www.unaids.org/ epi/2005/doc/EPIupdate2005_html_en/epi05_03_en.htm.
2. Centers for Disease Control and Prevention. Basic statistics: AIDS cases by exposure category. 2005. http://www.cdc. gov/hiv/stats.htm#exposure.
3. Centers for Disease Control and Prevention. Drug-associated HIV transmission continues in the United States. 2002. http://www.cdc.gov/hiv/pubs/ facts/idu.htm.
4. Update: syringe exchange programs - United States, 2002. MMWR Morb Mortal Wkly Rep 2005;54(27):673-6.
5. Frontline. Thirty years of America's drug war: a chronology. n.d. http://www.pbs.org/wgbh/pages/frontline/shows/drugs/ cron.
6. U.S. Office of National Drug Control Policy. Table 1: federal drug control spending by function: FY 2003-FY 2005. In: National drug control strategy: FY 2005 budget summary. Washington, DC: The Office; 2004. p. 6. http://www. whitehousedrugpolicy.gov/publications/policy/budgetsum04/ drug_control.pdf.
7. Substance Abuse and Mental Health Administration. Illicit drug use. In: Overview of findings from the 2004 National Survey on Drug Use and Health. Rockville, MD: The Administration; 2005. p.10-3. http://oas.samhsa.gov/ NSDUH/2k4NSDUH/2k4results/2k4results.htm#ch2.
8. Rethinking America's "War on Drugs" as a public-health issue. Lancet 2001;357(9261):971.
9. Schiraldi V, Ziedenberg J. Costs and benefits? The impact of drug imprisonment in New Jersey. Washington, DC: Justice Policy Institute; 2003 Oct. http://www.justicepolicy.org/ downloads/nj-low.pdf.
10. McAuliffe WE, Dunn R. Substance abuse treatment needs and access in the USA: interstate variations. Addiction 2004;99(8):999-1014.
11. Mumola CJ. Substance abuse and treatment, state and federal prisoners, 1997. Washington, DC: U.S. Department of Justice; 1999. NCJ 172871. http://www.ojp.usdoj.gov/bjs/ pub/pdf/satsfp97.pdf. [Bureau of Justice Statistics special report.]
12. Harm Reduction Coalition. [About HRC:] Principles of harm reduction. n.d. http://www.harmreduction.org.
13. Springer E. Harm reduction drug treatment: the time has come. 2003. http://www.harmreduction.org/pubs/news/ winter03/win03Springer.htm.
14. American Nurses Association. Code of ethics for nurses with interpretive statements. Washington, DC: The Association; 2001.
15. Strathdee SA, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11(8):F59-65.
16. Bruneau J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol 1997;146(12):994-1002.
17. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. J Acquir Immune Defic Syndr 2001;28(3):273-8.
18. Mansson AS, et al. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000;32(3):253-8.
19. Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev 2003;15(3):257-68.
20. Braine N, et al. Long-term effects of syringe exchange on risk behavior and HIV prevention. AIDS Educ Prev 2004;16(3):264-75.
21. HIV diagnoses among injection-drug users in states with HIV surveillance - 25 states, 1994-2000. MMWR Morb Mortal Wkly Rep 2003;52(27):634-6.
22. Centers for Disease Control and Prevention. Table 1. Estimated numbers of cases of HIV/AIDS, by year of diagnosis and selected characteristics of persons, 2001-2004 - 30 areas with confidential name-based HIV infection reporting. In: HIV/AIDS surveillance report: cases of HIV infection and AIDS in the United States, 2004. Atlanta: The Center; 2005. vol. 16. p. 10. http://www.cdc.gov/hiv/stats/ 2004SurveillanceReport.pdf.
23. Kelley M, et al. A cultural impact of needle exchange: the role of safer-injection mentors. Contemporary Drug Problems 2001;28:485-505.
24. Lazzarini Z. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users. Health Matrix Clevel 2001;11(1):85-128.
25. Human Rights Watch. (2004 Jun 25) U.S.: needle-exchange law helps to combat AIDS. http://hrw.org/english/docs/2004/ 06/24/usdom8951.htm.
26. Centers for Disease Control and Prevention. CDC's goals for HIV prevention. In: HIV prevention strategic plan through 2005. Atlanta: The Center; 2001. p. 2. http:// www.cdc.gov/hiv/pubs/prev-strat-plan.pdf.
27. VanderWaal CJ, et al. African-American injection drug users: tensions and barriers in HIV/AIDS prevention. Subst Use Misuse 2001;36(6-7):735-55.
28. Hagan H, et al. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat 2000;19(3):247-52.
29. Galea S, et al. Needle exchange programs and experience of violence in an inner city neighborhood. J Acquir Immune Defic Syndr 2001;28(3):282-8.
30. Marx MA, et al. Trends in crime and the introduction of a needle exchange program. Am J Public Health 2000;90(12): 1933-6.
31. Institute of Medicine. The effects of needle exchange programs. In: Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academies Press; 1995. p. 198-262.
32. Doherty MC, et al. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol 1997;145(8):730-7.
33. Centers for Disease Control and Prevention. HIV/AIDS among African Americans. 2005. http://www.cdc.gov/hiv/ topics/aa/resources/factsheets/aa.htm.
34. Rogers DE, Osborn JE. AIDS policy. Two divisive issues. JAMA 1993;270(4):494-5.
35. International Council of Nurses. The ICN code of ethics for nurses. Geneva, Switzerland: The Council; 2000. http:// www.icn.ch/icncode.pdf.
36. American Nurses Association. Needle exchange and HIV. 1997. http://www.nursingworld.org/readroom/position/ blood/blnedl.htm.
37. Gent CE. Needle exchange policy adoption in American cities: why not? Policy Sciences 2000;33(2):125-53.
38. The Project on Harm Reduction in the Health Care System. Non-prescription access: Table 1: state syringe statutes and regulations (excluding paraphernalia laws). 2005. http:// www.temple.edu/lawschool/phrhcs/otc.htm.
39. Centers for Disease Control and Prevention. Syringe exchange programs. 2002 Jan. http://www.cdc.gov/idu/ facts/aed_idu_syr.htm.
40. Rich JD, et al. Obstacles to needle exchange participation in Rhode Island. J Acquir Immune Defic Syndr 1999;21(5): 396-400.